Riyadh — Mubasher: Lana Medical Company reported a net profit of SAR 2.08 million during the first half (H1) of 2026, representing a 5.27% increase from the SAR 1.98 million in H1-25, according to the initial financial statements.
The company attributed the bottom-line growth primarily to a substantial rise in sales volume during H1-26.
Revenue for the period reached SAR 63.20 million, a 32.44% increase compared to SAR 47.72 million in H1-25.
Lana Medical stated that this growth was fueled by the continued expansion of the company's business scale and rising demand for its services, particularly within government projects.
Enhanced service quality further supported customer confidence and market positioning.
Total shareholders' equity, excluding non-controlling interests, rose by 5.66% to SAR 67.16 million in H1-26 from SAR 63.57 million a year earlier.
Earnings per share (EPS) remained stable at SAR 0.04 in H1-26 when compared with H1-25.
The company’s external auditor issued an unmodified opinion on the financial statements, and Lana Medical confirmed that no comparative figures were reclassified during the reporting period.
